• 1
    Group TDR. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J. Pediatr. 1994; 125: 177188.
  • 2
    White NH, Cleary PA, Dahms W et al. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J. Pediatr. 2001; 139: 804812.
  • 3
    Kelly H, Jones T, Byrne G. Diabetes – national action plan. Med. J. Aust. 1993; 159: 838.
  • 4
    Couper JJ, Jones TW, Donaghue KC et al. The Diabetes Control and Complications Trial. Implications for children and adolescents. Australasian Paediatric Endocrine Group. Med. J. Aust. 1995; 162: 369372.
  • 5
    Delamater AM. Psychological care of children and adolescents with diabetes. Pediatr. Diabetes 2009; 10 (Suppl. 12): 175184.
  • 6
    Spinks JJ, Haest J, Ross K et al. Paediatric Diabetes Services – evidence that expanding the workforce allows intensification of insulin regimens and improves glycaemic control. Arch. Dis. Child. 2009; 94: 646647.
  • 7
    Karvonen M, Viik-Kajander M, Moltchanova E et al. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 2000; 23: 15161526.
  • 8
    Federation ID. Diabetes Atlas, 2nd edn. Brussels, Belgium: IDF, 2003.
  • 9
    Haynes A, Bower C, Bulsara MK et al. Continued increase in the incidence of childhood Type 1 diabetes in a population-based Australian sample (1985–2002). Diabetologia 2004; 47: 866870.
  • 10
    Catanzariti L, Faulks K, Moon L et al. Australia's national trends in the incidence of Type 1 diabetes in 0–14-year-olds, 2000–2006. Diabet. Med. 2009; 26: 596601.
  • 11
    Ma RC, Chan JC. Diabetes: incidence of childhood type 1 diabetes: a worrying trend. Nat. Rev. Endocrinol. 2009; 5: 529530.
  • 12
    Australian Institute of Health and Welfare. Prevalence of Type 1 diabetes in Australian children, 2008. Diabetes series. 2011; No. 15. 2011 A.
  • 13
    Tamborlane WV, Bonfig W, Boland E. Recent advances in treatment of youth with Type 1 diabetes: better care through technology. Diabet. Med. 2001; 18: 864870.
  • 14
    McMahon SK, Airey FL, Marangou DA et al. Insulin pump therapy in children and adolescents: improvements in key parameters of diabetes management including quality of life. Diabet. Med. 2005; 22: 9296.
  • 15
    Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database Syst. Rev. 2008; (3): CD006297.
  • 16
    Langendam MW, Hooft L, De Vries H et al. Continuous glucose monitoring systems for type 1 diabetes mellitus. Cochrane Database Syst. Rev. 2009; (3): CD008101.
  • 17
    Australian Institute of Health and Welfare. Australia's health 2010. Australia's Health. No. 12. 2010 A.
  • 18
    Rewers M, Pihoker C, Donaghue K et al. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr. Diabetes 2009; 10 (Suppl. 12): 7181.
  • 19
    Pihoker C, Forsander G, Wolfsdorf J et al. The delivery of ambulatory diabetes care to children and adolescents with diabetes. Pediatr. Diabetes 2009; 10 (Suppl. 12): 5870.
  • 20
    Sjöblad S. Pediatric and Adolescent Diabetes. A National Care Program by the Swedish Society for Diabetology and Endocrinology. Lund: Studentlitteratur, 2008.
  • 21
    Swift PG, Skinner TC, de Beaufort CE et al. Target setting in intensive insulin management is associated with metabolic control: the Hvidoere childhood diabetes study group centre differences study 2005. Pediatr. Diabetes 2010; 11: 271278.
  • 22
    Lin A, Northam EA, Rankins D et al. Neuropsychological profiles of young people with type 1 diabetes 12 yr after disease onset. Pediatr. Diabetes 2010; 11: 235243.
  • 23
    American Diabetes Association. Executive summary: standards of medical care in diabetes – 2011. Diabetes Care 2011; 34 (Suppl. 1): S410.
  • 24
    American Diabetes Association. Standards of medical care in diabetes – 2011. Diabetes Care 2011; 34 (Suppl. 1): S1161.
  • 25
    Craig ME, Twigg SM, Donaghue KC et al. for the Group ATDGEA. National evidence based clinical care guidelines for type 1 diabetes in children, adolescents and adults. Australian Government Department of Health and Ageing, Canberra. 2011.
  • 26
    Chalew S. Continuing stability of center differences in pediatric diabetes care: do advances in diabetes treatment improve outcome? The Hvidoere Study Group on Childhood Diabetes: response to de Beaufort et al. Diabetes Care 2008; 31: e27; author reply e28.
  • 27
    Bulsara MK, Holman CD, Davis EA et al. The impact of a decade of changing treatment on rates of severe hypoglycemia in a population-based cohort of children with type 1 diabetes. Diabetes Care 2004; 27: 22932298.
  • 28
    de Boer IH, Sun W, Cleary PA et al. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N. Engl. J. Med. 2011; 365: 23662376.